SCHEMBL29566398

SCHEMBL29566398

CN1CCC(c2ccc(Oc3nc(NS(=O)(=O)c4cnn(C)c4)nc(Cl)c3C3CC3)cc2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K3 Q8IVH8 1/20 0.35
▸ MAP4K1 Q92918 1/20 0.35
▸ HTR1A P08908 5/20 0.34
▸ HTR7 P34969 5/20 0.34
▸ BRD4 O60885 4/20 0.34
▸ EGFR P00533 2/20 0.34
▸ SLC8A1 P32418 1/20 0.34
▸ ALK Q9UM73 1/20 0.34
▸ JAK2 O60674 2/20 0.33
▸ SLC6A9 P48067 1/20 0.33
▸ NPBWR1 P48145 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309437 1.00 MAP4K3 (0.35) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL24309771 0.87 PTK2 (0.35) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL29567013 0.87 PTK2 (0.35) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL29567027 0.86 BRD4 (0.35) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL24309451 0.86 BRD4 (0.35) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL24309993 0.85 BRD4 (0.36) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL29566770 0.85 BRD4 (0.36) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL24309436 0.85 HTR1A (0.36) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL24310440 0.82 HTR1A (0.34) MAP4K3MAP4K1HTR1AHTR7BRD4
SCHEMBL29566951 0.82 HTR1A (0.34) MAP4K3MAP4K1HTR1AHTR7BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback